menu
    • menu
    [{"orgOrder":0,"company":"Genetron Health","sponsor":"CStone Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"CHINA","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Avapritinib","moa":"KIT\/PDGFA receptor","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Genetron Health","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Oral Tablet, Film Coated","sponsorNew":"Genetron Health \/ Genetron Health","highestDevelopmentStatusID":"15","companyTruncated":"Genetron Health \/ Genetron Health"},{"orgOrder":0,"company":"Genetron Health","sponsor":"CStone Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"CHINA","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Avapritinib","moa":"KIT\/PDGFA receptor","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Genetron Health","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Oral Tablet, Film Coated","sponsorNew":"Genetron Health \/ Genetron Health","highestDevelopmentStatusID":"15","companyTruncated":"Genetron Health \/ Genetron Health"}]

    Find Clinical Drug Pipeline Developments & Deals by Genetron Health

    Menu

    Genetron Health

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Genetron Health

                            U.S.A arrow
                            AGGSpend
                            Not Confirmed

                            Genetron Health

                            U.S.A arrow
                            AGGSpend
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Avapritinib

                            Therapeutic Area : Oncology

                            Study Phase : Approved FDF

                            Recipient : CStone Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            CStone gets NMPA Approval for AYVAKIT CDx Kit Developed with Genetron

                            Details : Ayvakit (avapritinib) is a tyrosine kinase inhibitor that targets KIT D816V, PDGFRA and PDGFRA D842 mutants, indicated for gastrointestinal stromal tumors.

                            Product Name : Ayvakit

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            September 27, 2023

                            Lead Product(s) : Avapritinib

                            Therapeutic Area : Oncology

                            Highest Development Status : Approved FDF

                            Recipient : CStone Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Genetron Health

                            U.S.A arrow
                            AGGSpend
                            Not Confirmed

                            Genetron Health

                            U.S.A arrow
                            AGGSpend
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Avapritinib

                            Therapeutic Area : Oncology

                            Study Phase : Approved FDF

                            Recipient : CStone Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            CStone and Genetron Launch Avapritinib CDx Clinical Trial in China

                            Details : Ayvakit (avapritinib) is a tyrosine kinase inhibitor that targets KIT D816V, PDGFRA and PDGFRA D842 mutants, indicated for gastrointestinal stromal tumors.

                            Product Name : Ayvakit

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            September 25, 2020

                            Lead Product(s) : Avapritinib

                            Therapeutic Area : Oncology

                            Highest Development Status : Approved FDF

                            Recipient : CStone Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth